- |||||||||| SYN004 / Synermore, SYN125 / Synermore
Enrollment closed, Enrollment change, Trial completion date, Trial primary completion date, Combination therapy: A Study to Find the MTD of SYN125 in People With Solid Tumors and the MTD of SYN125 With a Fixed Dose of SYN004 in People in Patients With Epithelial Cancers With EGFR Expressions (clinicaltrials.gov) - Apr 12, 2023 P1, N=22, Active, not recruiting, Recruiting --> Active, not recruiting | N=36 --> 22 | Trial completion date: May 2022 --> Sep 2023 | Trial primary completion date: Feb 2022 --> Jul 2023
|